LYEL · Lyell Immunopharma, Inc. · Proposed Sales
$9.70
+0.90 (+10.23%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$215.65M
Shares
24.51M
Volume · Oct 20
157.01K
Avg daily vol (3M)
154.06K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2023-08-15 | Klausner Richard | Director | 4,485 | 2023-08-15 | Raymond James & Associates, Inc. |
| 2023-08-15 | Klausner Richard | Director | 4,485 | 2023-08-15 | Raymond James & Associates, Inc. |
| 2023-08-15 | Klausner Richard | Director | 44,565 | 2023-08-15 | Raymond James & Associates, Inc. |
| 2023-08-15 | Klausner Richard | Director | 4,485 | 2023-08-15 | Raymond James & Associates, Inc. |
| 2023-07-17 | Klausner Richard | Officer, Director | 3,300 | 2023-07-13 | Raymond James & Associates, Inc. |
| 2023-07-17 | Klausner Richard | Officer, Director | 3,300 | 2023-07-13 | Raymond James & Associates, Inc. |
| 2023-07-17 | Klausner Richard | Officer, Director | 3,300 | 2023-07-13 | Raymond James & Associates, Inc. |
| 2023-07-17 | Klausner Richard | Officer, Director | 14,500 | 2023-07-13 | Raymond James & Associates, Inc. |
Showing 1–8 of 8 filings